Incidence, Predictors, and Outcomes Related to Hypo- and Hyperkalemia in Patients With Severe Heart Failure Treated With a Mineralocorticoid Receptor Antagonist-Reference-Cited by-同舟云学术

Incidence, Predictors, and Outcomes Related to Hypo- and Hyperkalemia in Patients With Severe Heart Failure Treated With a Mineralocorticoid Receptor Antagonist

Published:2014-07 Issue:4 Volume:7 Page:573-579
ISSN:1941-3289
Container-title:Circulation: Heart Failure
language:en
Short-container-title:Circ Heart Fail

Author:

Vardeny Orly¹,Claggett Brian¹,Anand Inder¹,Rossignol Patrick¹,Desai Akshay S.¹,Zannad Faiez¹,Pitt Bertram¹,Solomon Scott D.¹

Affiliation:

1. From the Department of Pharmacy, University of Wisconsin School of Pharmacy, Madison, WI (O.V.); Department of Medicine, Brigham and Women’s Hospital, Boston, MA (B.C., A.S.D., S.D.S.); VA Medical Center and University of Minnesota, Minneapolis (I.A.); INSERM, Centre d’Investigations Cliniques-9501 and INSERM U1116, Nancy, France (P.R., F.Z.); Department of Cardiology (F.Z.) and Department of Nephrology (P.R.), Université de Lorraine, Nancy, France; and Department of Medicine, University of Michigan...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference22 articles.

1. The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

2. Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

3. Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction

4. Use of Aldosterone Antagonists in Heart Failure

5. Heart Failure Care in the Outpatient Cardiology Practice Setting

Cited by 168 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The relationship between potassium levels and 28-day mortality in sepsis patients: Secondary data analysis using the MIMIC-IV database;Heliyon;2024-06

2. How to tackle therapeutic inertia in heart failure with reduced ejection fraction. A scientific statement of the Heart Failure Association of the ESC;European Journal of Heart Failure;2024-05-22

3. Sodium Zirconium Cyclosilicate in HFrEF and Hyperkalemia;JACC: Heart Failure;2024-05

4. Mineralocorticoid receptor antagonist for chronic kidney disease, risk or benefit?;Journal of Hypertension;2024-02-01

5. Mineralocorticoid receptor antagonist treatment in patients with renal insufficiency and the associated risk of hyperkalemia and death;Journal of Hypertension;2023-12-14